Cargando…
Mammary stem cell number as a determinate of breast cancer risk
The 'cancer stem cell hypothesis' posits that cancers, including breast cancer, arise in tissue stem or progenitor cells. If this is the case, then it follows that the risk for developing breast cancer may be determined in part by the number of breast stem/progenitor cells that can serve a...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206714/ https://www.ncbi.nlm.nih.gov/pubmed/17688678 http://dx.doi.org/10.1186/bcr1741 |
_version_ | 1782148496516710400 |
---|---|
author | Ginestier, Christophe Wicha, Max S |
author_facet | Ginestier, Christophe Wicha, Max S |
author_sort | Ginestier, Christophe |
collection | PubMed |
description | The 'cancer stem cell hypothesis' posits that cancers, including breast cancer, arise in tissue stem or progenitor cells. If this is the case, then it follows that the risk for developing breast cancer may be determined in part by the number of breast stem/progenitor cells that can serve as targets for transformation. Stem cell number may be set during critical windows of development, including in utero, adolescence, and pregnancy. The growth hormone/insulin-like growth factor-1 axis may play an important role in regulating breast stem cell number during these developmental windows, suggesting an important link between this signaling pathway and breast cancer risk. |
format | Text |
id | pubmed-2206714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-22067142008-01-19 Mammary stem cell number as a determinate of breast cancer risk Ginestier, Christophe Wicha, Max S Breast Cancer Res Editorial The 'cancer stem cell hypothesis' posits that cancers, including breast cancer, arise in tissue stem or progenitor cells. If this is the case, then it follows that the risk for developing breast cancer may be determined in part by the number of breast stem/progenitor cells that can serve as targets for transformation. Stem cell number may be set during critical windows of development, including in utero, adolescence, and pregnancy. The growth hormone/insulin-like growth factor-1 axis may play an important role in regulating breast stem cell number during these developmental windows, suggesting an important link between this signaling pathway and breast cancer risk. BioMed Central 2007 2007-07-31 /pmc/articles/PMC2206714/ /pubmed/17688678 http://dx.doi.org/10.1186/bcr1741 Text en Copyright © 2007 BioMed Central Ltd |
spellingShingle | Editorial Ginestier, Christophe Wicha, Max S Mammary stem cell number as a determinate of breast cancer risk |
title | Mammary stem cell number as a determinate of breast cancer risk |
title_full | Mammary stem cell number as a determinate of breast cancer risk |
title_fullStr | Mammary stem cell number as a determinate of breast cancer risk |
title_full_unstemmed | Mammary stem cell number as a determinate of breast cancer risk |
title_short | Mammary stem cell number as a determinate of breast cancer risk |
title_sort | mammary stem cell number as a determinate of breast cancer risk |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206714/ https://www.ncbi.nlm.nih.gov/pubmed/17688678 http://dx.doi.org/10.1186/bcr1741 |
work_keys_str_mv | AT ginestierchristophe mammarystemcellnumberasadeterminateofbreastcancerrisk AT wichamaxs mammarystemcellnumberasadeterminateofbreastcancerrisk |